Julian Baker’s Mural Oncology MURA Stock Holding History

Julian Baker’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-222,503	Closed	-$1.09M	–	99
2024 Q1	$1.09M	Buy	+222,503	New	+$1.08M	0.01%	78

Other funds holding MURA

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Julian Baker's MURA Position: Q2 2024 in Review

Julian Baker sold out of Mural Oncology (MURA) in Q2 2024, closing a stake of 222,503 shares — an estimated $1.09M sold.

Julian Baker first reported a position in MURA in Q1 2024 and held it in 1 quarter. The position peaked at $1.09M in Q1 2024. 86 funds tracked by Wall St. Rank hold MURA as of Q2 2024.

Julian Baker reported no remaining Mural Oncology position as of Q2 2024 after selling out during the quarter.
Julian Baker sold 222,503 Mural Oncology shares in Q2 2024, an estimated $1.09M.
Julian Baker first reported a position in Mural Oncology in Q1 2024 and held it in 1 quarter.
Julian Baker's Mural Oncology position peaked at $1.09M in Q1 2024.
86 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2024.

Based on Baker Bros. Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.